In-silico simulated prototype-patients using TPMS technology to study a potential adverse effect of sacubitril and

Guillem Jorba1,2, Joaquim Aguirre-Plans2, Valentin Junet1,3

  • 1Anaxomics Biotech SL, Barcelona, Catalonia, Spain.

Plos One
|February 14, 2020
PubMed